INCYTE

Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. Incyte's product pipeline is currently focused on oncology and inflammation and includes compounds in various stages of development. Through partnerships with [Novartis](/organization/novartis), [Eli Lilly](/organization/eli-lilly), and [Pfizer](/organization/pfizer), Incyte intends to promote the clinical development and global commercialization of several of their compounds.
INCYTE
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
1991-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.incyte.com
Total Employee:
501+
Status:
Active
Contact:
855-463-3463
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Brizzey
Brizzey is a firm of seasoned professionals, which guides and supports companies in planning, production, global distribution.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
PanTheryx
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Promiliad Biopharma
Promiliad Biopharma is an innovative drug discovery company that creates novel natural product-like small molecules.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2016-05-09 | ARIAD Pharmaceuticals - European operations | ARIAD Pharmaceuticals - European operations acquired by Incyte | 275 M USD |
2003-02-18 | Maxia Pharmaceuticals | Maxia Pharmaceuticals acquired by Incyte | N/A |
2000-12-01 | Proteome | Proteome acquired by Incyte | N/A |
1998-01-22 | Synteni | Synteni acquired by Incyte | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2017-02-14 | Agenus | Incyte investment in Post-IPO Equity - Agenus | 60 M USD |
2002-03-27 | Iconix Biosciences | Incyte investment in Venture Round - Iconix Biosciences | 20 M USD |
2001-07-26 | De Novo Pharmaceuticals | Incyte investment in Series B - De Novo Pharmaceuticals | 16.75 M GBP |
2000-06-26 | GeneEd | Incyte investment in Seed Round - GeneEd | 2 M USD |
Official Site Inspections
http://www.incyte.com Semrush global rank: 494.63 K Semrush visits lastest month: 101.15 K
- Host name: 20.119.8.32
- IP address: 20.119.8.32
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Incyte"
Incyte - Wikipedia
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. [2] The company currently operates manufacturing and R&D locations …See details»
Incyte Biosciences CANADA - Biopharmaceutical …
Incyte Biosciences CANADA Incyte is a global biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. World-class science and R&D drive Incyte’s business and its …See details»
Incyte: A Global Biopharmaceutical Company on a …
Oct 19, 2023 Incyte is a global biopharmaceutical company using science to help address patients’ unmet needs. Focusing on patients and innovation and leveraging 2,400 employees and more than 1,000 world-class scientists, …See details»
Incyte - Crunchbase Company Profile & Funding
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.See details»
Investors | Incyte
Jun 15, 2025 The Investor Relations website contains information about Incyte's business for stockholders, potential investors, and financial analysts.See details»
Incyte Corporation Careers
Incyte prefers to recruit candidates directly rather than through a third-party recruiter or agency. Incyte will only pay a fee for candidates submitted or presented where there is a signed …See details»
Incyte - bioforward.org
Incyte’s unique expertise in medicinal chemistry and biology has enabled us to establish a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology …See details»
Incyte Leadership | Incyte.com
Prior to Incyte, Mr. Trotta served as the Head of Novartis U.S. Immunology, where he led a 400-person organization across dermatology, rheumatology, auto-inflammatory rare diseases and allergy. He additionally held leadership roles …See details»
Solutions for Unmet Medical Needs - Incyte
Incyte is a global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.See details»
Global Biopharmaceutical Company | Incyte
Incyte is a global biopharmaceutical company that has created a robust and diversified portfolio of marketed products and clinical candidates in oncology, inflammation, and autoimmunity.See details»
Company Profile for Incyte Corporation | Incyte
Nov 07, 2003 -- Incyte is a drug discovery company that is using its expertise in genomics, medicinal chemistry and molecular, cellular and in vivo biology to discover and develop novel …See details»
Global Biopharmaceutical Company | Incyte.com
Incyte is a global biopharmaceutical company that has created a robust and diversified portfolio of marketed products and clinical candidates in oncology and inflammation and autoimmunity.See details»
Incyte: A biopharmaceutical company with brains and heart
Feb 11, 2022 With headquarters in Wilmington, Delaware, and offices worldwide, the biopharmaceutical company Incyte, offers plenty of professional and personal growth …See details»
Incyte Appoints Bill Meury Chief Executive Officer; Hervé …
5 days ago - Three-decade industry leader, former CEO of Karuna and Anthos and Chief Commercial Officer of Allergan, Bill Meury , joins Incyte as President and CEO - Hervé …See details»
From A Small Team of Research Scientists, Chemists ... - incyte.com
Read the story of how Incyte was started 20 years ago by a small team working in immunology and willing to tackle difficult medical problems.See details»
Global Responsibility - Incyte.com
Read Incyte’s responsibility statement explaining how they aim to operate their business in a way that builds trust, protects the environment and enhances communities.See details»
Incyte Corporation
Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. For additional information on Incyte, please visit …See details»
Incyte's CEO transition raises M&A hopes - fiercepharma.com
4 days ago After over a decade spent building Incyte up into a competitive commercial drugmaker, the company’s longtime CEO Hervé Hoppenot is making his exit and passing the …See details»
Incyte Stock Pops As New CEO Appointment Stokes M&A …
4 days ago Incyte stock popped Thursday after the company's board appointed Bill Meury as its new CEO, replacing Herve Hoppenot, who is retiring.See details»
Incyte Appoints Bill Meury Chief Executive Officer; Hervé …
5 days ago - Three-decade industry leader, former CEO of Karuna and Anthos and Chief Commercial Officer of Allergan, Bill Meury, joins Incyte as President and CEO - Hervé …See details»